Preventive Health Is a Strategy for Health Financing

There is a quiet arithmetic that often slips from discussions about health financing: “money not spent is money saved.” While it may sound simplistic, it can serve as a foundational principle for any sustainable system, economic or otherwise.

In recent years, the dialogue around health financing has become popular yet narrow, focusing almost exclusively on larger budgets, expanded insurance schemes, increased donor flows, and new funding mechanisms. These elements are undeniably important, but they represent only one side of the equation. Financing health is not just about how much money enters the system; it is also about preventing unnecessary expenditure from occurring in the first place. This is where preventive health quietly stands as one of the most underutilized financing strategies.

Prevention is often framed as a moral or clinical responsibility—something good to do for public health—but not as a fiscal strategy. Yet, at its core, prevention is an exercise in economic discipline.

A well‑prevented illness is not only a life improved; it is a cost avoided, a drug regimen that was never needed, and, in many cases, a financial burden that never fell on a household.

In a country where out‑of‑pocket expenditure still determines access to care for many citizens, this distinction matters deeply. When people stay healthier for longer, they spend less on treatment. When communities adopt preventive behaviors, the strain on health facilities decreases. When systems prioritize early detection and risk reduction, the cost curve bends—not because more money is spent, but because less money is needed.

This is not an argument against mobilizing more funds for health. On the contrary, it is a call to think more intelligently about what “financing health” truly means. Generating revenue is one part. Structuring systems efficiently is another. And, crucially, reducing avoidable expenditure must sit at the center of that conversation.

Interestingly, this broader view aligns with deeper conversations about governance and federal structure. True federalism, as many have argued, is not just about distributing resources but about enabling systems to function efficiently at all levels. Recent legislative developments in that direction are, for once, a step that deserves cautious commendation. They suggest that we may be beginning to think beyond surface‑level reforms and toward more grounded, structural solutions.

But policy frameworks alone will not carry this shift. Preventive health requires a subtle cultural and systemic reorientation. It asks us to value the absence of disease as much as the treatment of it. It asks governments to invest in awareness, early screening, community‑based interventions, and primary care—not as afterthoughts, but as core financing strategies.

It also demands that we confront an uncomfortable truth: reactive healthcare is expensive. A system that waits for illness to occur before acting will always spend more than one that works to prevent it. Hospitals will remain congested, costs will continue to rise, and households will keep absorbing financial shocks that could have been avoided.

On the other hand, a preventive‑focused system redistributes that burden, spreading cost‑saving across individuals, communities, and institutions. It is quieter, less dramatic, and often less politically celebrated, but far more sustainable.

A human dimension that cannot be ignored is that financial protection in health should not be limited to insurance coverage or subsidies; it is about reducing the likelihood that people will need to spend in the first place. Every avoided illness is, in a real sense, a preserved livelihood.

Perhaps it is time we expanded our definition of health financing. Beyond budgets and allocations, beyond policies and programs, we must begin to recognize prevention as a financial instrument in its own right.

Oladoja Mark Olamilekan, Abuja